Vanguard Group’s GeoVax Labs GOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$41.8K Hold
9,767
﹤0.01% 4262
2025
Q3
$115K Buy
9,767
+5,161
+112% +$90.3K ﹤0.01% 4209
2025
Q2
$99.7K Hold
4,606
﹤0.01% 4149
2025
Q1
$122K Buy
4,606
+2,560
+125% +$113K ﹤0.01% 4116
2024
Q4
$126K Buy
2,046
+1,276
+166% +$73.9K ﹤0.01% 4151
2024
Q3
$46.4K Hold
770
﹤0.01% 4249
2024
Q2
$61.3K Hold
770
﹤0.01% 4275
2024
Q1
$38.5K Sell
770
-1,173
-60% -$92.5K ﹤0.01% 4338
2023
Q4
$263K Hold
1,943
﹤0.01% 4180
2023
Q3
$374K Sell
1,943
-6
-0.3% -$1.26K ﹤0.01% 4137
2023
Q2
$402K Hold
1,949
﹤0.01% 4178
2023
Q1
$486K Hold
1,949
﹤0.01% 4131
2022
Q4
$461K Buy
1,949
+482
+33% +$146K ﹤0.01% 4119
2022
Q3
$600K Buy
1,467
+777
+113% +$448K ﹤0.01% 4164
2022
Q2
$215K Hold
690
﹤0.01% 4460
2022
Q1
$298K Hold
690
﹤0.01% 4472
2021
Q4
$937K Sell
690
-1
-0.1% -$1.48K ﹤0.01% 4285
2021
Q3
$1.12M Buy
691
+7
+1% +$12.2K ﹤0.01% 4224
2021
Q2
$1.28M Buy
684
+549
+407% +$1.07M ﹤0.01% 4101
2021
Q1
$221K Buy
135
+76
+129% +$148K ﹤0.01% 4244
2020
Q4
$75K Buy
+59
New +$68.6K ﹤0.01% 4162

Other funds holding GOVX

Vanguard Group's GOVX Position: Q4 2025 in Review

Vanguard Group held its GeoVax Labs (GOVX) position steady in Q4 2025 at 9,767 shares worth $41.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4262.

Vanguard Group first reported a position in GOVX in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.28M in Q2 2021. 19 funds tracked by Wall St. Rank hold GOVX as of Q4 2025.

  • Vanguard Group held 9,767 shares of GeoVax Labs worth $41.8K as of Q4 2025.
  • Vanguard Group left its GeoVax Labs share count unchanged in Q4 2025.
  • GeoVax Labs made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4262 holding.
  • Vanguard Group first reported a position in GeoVax Labs in Q4 2020 and has held it in 21 quarters since.
  • Vanguard Group's GeoVax Labs position peaked at $1.28M in Q2 2021.
  • 19 funds tracked by Wall St. Rank held GeoVax Labs as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.